Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/1999
12/14/1999US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999US6001358 Useful for treatment of autoimmune diseases
12/14/1999CA2010636C Substituted pyrroles
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999WO1999062507A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
12/09/1999WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/08/1999EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999EP0775158B1 Cyclopeptolides
12/08/1999EP0730587B1 3-phenyl-2-isoxazolines as antiinflammatory agents
12/08/1999CN1237955A Substituted phenols and thiophenols useful as antioxidant agents
12/08/1999CN1237904A New use of creatine
12/08/1999CN1237435A Oral medicine for curing phlegm-heat cough
12/07/1999US5998586 Interleukin-5 specific recombinant antibodies
12/07/1999US5998469 Nervous system diosrders; autoimmune diseases; antiinflammatory agents
12/07/1999US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999US5998425 Cytokine antagonist; antiarthritic agent
12/07/1999US5998403 Salts of azelastine having improved solubility useful at providing a cytoprotective effect
12/07/1999US5998390 Combination of bisphosphonate and tetracycline
12/07/1999US5998169 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999CA2161886C Heteroatom substituted alkylbenzylaminoquinuclidines
12/07/1999CA2140768C A method of increasing creatine supply depot
12/07/1999CA2012686C Treatment and compounds
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999WO1999061025A1 Microemulsion preconcentrates containing a piperidine substance p antagonist
12/02/1999WO1999061020A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE
12/02/1999WO1999061019A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
12/02/1999WO1999061013A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
12/02/1999WO1999061012A2 Therapeutic dinucleotide and derivatives
12/02/1999WO1999061003A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999WO1999060999A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
12/02/1999WO1999060998A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
12/02/1999WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2332999A1 Compounds having ige affecting properties
12/02/1999CA2332989A1 Benzimidazole derivatives as modulators of ige
12/02/1999CA2332985A1 Benzimidazole analogs as down-regulators of ige
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2332540A1 Therapeutic dinucleotide and derivatives
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2332371A1 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract
12/02/1999CA2332369A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999CA2329072A1 Human transmembrane proteins
12/01/1999EP0960191A1 Compositions and methods for use of defensin
12/01/1999EP0960096A1 SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999EP0959874A1 High dose liposomal aerosol formulations
12/01/1999EP0582631B1 Use of S-nitrosothiols for the preparation of a medicament for the relaxation of smooth muscle
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1237159A Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments
12/01/1999CN1046939C Fluoroalkoxy-substituted benzamides and their preparing process and use
11/1999
11/30/1999USRE36420 Percutaneous preparation of tulobuterol
11/30/1999US5994549 Piperidine derivatives and process for their production
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994376 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994344 Bronchitis therapy
11/30/1999US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999US5994315 Low adenosine agent, composition, kit and method for treatment of airway disease
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994096 Regulator
11/30/1999US5993859 Pharmaceutical agents
11/30/1999US5993814 Agents for inhibition of chemoattractant
11/30/1999US5993783 Aerosols
11/30/1999US5993781 Fluticasone propionate nebulizable formulations
11/30/1999CA2179011C 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
11/25/1999WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999WO1999059972A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059964A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999WO1999059617A2 Immunoregulator
11/25/1999WO1999059553A1 Effervescent preparations
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation
11/25/1999CA2328509A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/24/1999EP0958823A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation
11/24/1999EP0958277A1 Nitric oxide synthase inhibitors
11/24/1999EP0957907A1 Il-8 receptor antagonists
1 ... 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 ... 878